![Eduard Enrico Holdener](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eduard Enrico Holdener
Chairman at
NOVIMMUNE SA
Profile
Eduard Enrico Holdener is currently the Chairman at NovImmune SA, Director at Cellerix SA, and Director at Swiss Cancer Foundation.
Previously, he served as an Independent Director at PAREXEL International Corp.
from 2015 to 2017, Independent Director at TiGenix NV, Director at HBM Healthcare Investments AG from 2008 to 2021, Non-Executive Director at Ipsen Bioinnovation Ltd., Head of Drug Development at Roche Holding AG from 1995 to 2007, and Chief Medical Officer at F.
Hoffmann-La Roche Ltd. in 2008.
Holdener holds a doctorate degree from the University of Basel and the University of Zurich.
Eduard Enrico Holdener active positions
| Companies | Position | Start |
|---|---|---|
| NOVIMMUNE SA | Chairman | 2008-01-31 |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | 2008-12-31 |
Swiss Cancer Foundation | Director/Board Member | - |
Former positions of Eduard Enrico Holdener
| Companies | Position | End |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Director/Board Member | 2021-06-17 |
| PAREXEL INTERNATIONAL CORPORATION | Director/Board Member | 2017-09-28 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | 2008-01-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2006-12-31 |
| TIGENIX NV | Director/Board Member | - |
Training of Eduard Enrico Holdener
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Novimmune SA
 Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Swiss Cancer Foundation | |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
- Stock Market
- Insiders
- Eduard Enrico Holdener
